Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UiPath Inc (PATH) vs Verisign, Inc. (VRSN) Price & Performance

UiPath IncTrade
Verisign, Inc.Trade

Price performance (Past 24H)

Key statistics

UiPath Inc vs Verisign, Inc. — how do they compare? UiPath Inc trades at $13.59 (market cap $7.26B), while Verisign, Inc. trades at $286.99 (market cap $25.51B). The key difference: Verisign, Inc. is far larger — about 3.5× UiPath Inc's market cap, and Verisign, Inc. pays a 1.15% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.

PATHVRSN
Market Cap
$7.26B$25.51B
Sector
TechnologyTechnology
52-Week High
$19.29$310.00
52-Week Low
$9.38$211.49
Enterprise Value
$6.05B$26.82B
Dividend Yield
1.15%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UiPath Inc

UiPath (PATH) trades at $14.01, down 7.77% amid mixed signals. The stock is near its consensus price target low of $14.00. Revenue growth is improving, with 2025 revenue at $1.43 billion and a projected net profit margin of 21.03% for 2026. Technical indicators show a bearish near-term trend with RSI at oversold levels, while recent news highlights volatility following Q2 earnings.

The outlook is cautious; PATH shows fundamental improvement but faces execution risks and competitive pressure. Analyst consensus is predominantly Hold (70.84%), with a $17.38 price target suggesting modest upside. Key risks include slowing growth guidance and macroeconomic headwinds impacting software demand.

Verisign, Inc.

VeriSign (VRSN) trades at $282.20, down 3.38% on the day, with a bearish technical signal but strong fundamentals including a 49.77% net income margin and record domain registrations. Recent Q2 2026 earnings beat estimates with EPS of $2.38, though Q4 2025 and Q2 2026 missed expectations. The stock faces headwinds from an antitrust lawsuit filed in September 2026, but institutional buying by firms like BlackRock signals confidence.

Outlook is mixed: bullish analyst consensus with a $328.50 price target suggests 16% upside, supported by AI-driven domain growth and a pending .web delegation. Risks include legal overhangs and competitive pressures. The current valuation at a P/E of 30.64 may limit near-term gains unless earnings accelerate.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN